Compare Google Inc (GOOG) vs Hims and Hers Health Inc (HIMS) Price & Performance

Alphabet (GOOG) trades at $344.86, down 0.72% today, with a bullish technical signal from moving averages and strong support near $342. The company reported robust Q2 2026 EPS of $9.11, beating expectations, with revenue growth accelerating to $402.84B in 2025. Analyst consensus is strongly bullish with an 87% buy rating and a $435.24 price target, though recent news highlights rising capital expenditures and potential free cash flow pressures.

Outlook remains positive driven by AI and cloud expansion, but risks include heightened spending, regulatory scrutiny, and class-action lawsuits. The stock's valuation at a P/E of 17.3 appears reasonable given high profitability margins, positioning it for long-term growth if execution continues.

HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.

The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.